The New Relationship Dilemma: Evaluating Physician Payment Transparency Regulations


The struggle is real. As an executive in health care, I understand the impact regulation has on our business.  No doubt, physicians and pharmaceutical companies feel it as well: especially given some very significant changes that have transpired over the past 20 months. The Physician Financial Transparency Reports, or Sunshine Act, requires increased reporting of financial relationships between health care providers and pharmaceutical manufacturers and sheds light on potential conflicts of interest. Ultimately, the Act surmises, patients would have a better opportunity to learn about potential conflicts and consider those in the context of their prescribed treatment. But like others, well-intentioned legislations, I sometimes wonder how the Act is working.
[Read more…]

Technologies for Gathering and Processing Transfers of Value when Reporting on Events


To satisfy Open Payment mandates a great deal of information must be collected, verified, validated and organized. At events, meeting managers must record every transaction in a way that facilitates assignment to multiple participants. Attendance details must be thoroughly recorded for the main event as well as any sub-event. Attendee identities should be validated and include NPI numbers (and, depending on other technology, state license information).
[Read more…]

Key Compliance Issues to Keep an Eye On in 2015: Off-Label Marketing and Sunshine Act Reporting


As we near the midpoint of 2015, pharmaceutical and medical device manufacturers should take some time to review their compliance policies and related implementation strategies to help protect against potential liability.  This article addresses two compliance issues that should be near the top of every compliance officer’s checklist: (1) off-label marketing and (2) Sunshine Act reporting.
[Read more…]